Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in moderate to severe chronic plaque psoriasis
NCT01045577Phase 2Completed
- Sponsor
- AB Science
- Start
- Sep 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of masitinib in plaque psoriasis, sponsored by AB Science. Started Sep 2005; status: completed.
02
Drugs
masitinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01045577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045577.